Citi Reiterates Sell Rating on Hims and Hers (HIMS), 'We think HIMS will not make any margin on dispensing of Wegovy'
Tweet Send to a Friend
Citi analyst Daniel Grosslight reiterated a Sell rating and $25.00 price target on Hims and Hers (NYSE: HIMS)The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
